From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care
Bibliographic record
Abstract
Neurofibromatosis (NF) presents a significant clinical challenge due to its complex genetic basis, diverse clinical manifestation, and substantial impact on a patient's quality of life (QoL). This paper explores the multifaceted approach required to manage NF in Canada, emphasizing the integration of advanced diagnostic tools, targeted treatments, and comprehensive support systems. Healthcare providers, researchers, patient advocacy groups, and policymakers must collaborate to ensure NF patients receive the best possible care and support. This disease poses devastating consequences to families, and there has been a lack of awareness of this issue in Vancouver and, generally, in British Columbia. Currently, there is no clinic dedicated explicitly to NF in Metro Vancouver, and patients diagnosed with this disease must be flown to Toronto to get treated. The process is costly and inefficient, demanding changes. Some recent improvements in the field of NF have been noted, such as the use of gene therapy and MEK inhibitors. However, the long-term effect of this treatment is largely unknown and should be viewed with caution. This underscores the importance of enhancing psychological interventions to address the mental health challenges faced by NF patients. Specific gene sequences for different types of NF have also been mentioned in the article to offer insights on potential targets for gene-editing technology like CRISPR. Through ongoing advancements in medical science and a commitment to patient-centered care, this paper envisions significant improvements in the management and treatment of this complex condition.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.004 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.001 | 0.002 |
| Science and technology studies | 0.014 | 0.005 |
| Scholarly communication | 0.007 | 0.002 |
| Open science | 0.002 | 0.005 |
| Research integrity | 0.003 | 0.005 |
| Insufficient payload (model declined to judge) | 0.007 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".